These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 34071559)

  • 1. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.
    Šudomová M; Berchová-Bímová K; Marzocco S; Liskova A; Kubatka P; Hassan STS
    Viruses; 2021 May; 13(6):. PubMed ID: 34071559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of berberine.
    Warowicka A; Nawrot R; Goździcka-Józefiak A
    Arch Virol; 2020 Sep; 165(9):1935-1945. PubMed ID: 32594322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of protein kinase inhibitors for treating herpesvirus-associated disease.
    Li R; Hayward SD
    Trends Microbiol; 2013 Jun; 21(6):286-95. PubMed ID: 23608036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview: cytomegalovirus and the herpesviruses in transplantation.
    Fishman JA
    Am J Transplant; 2013 Feb; 13 Suppl 3():1-8; quiz 8. PubMed ID: 23347210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.
    Field AK; Biron KK
    Clin Microbiol Rev; 1994 Jan; 7(1):1-13. PubMed ID: 8118786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses.
    Hassan STS; Šudomová M; Mazurakova A; Kubatka P
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra.
    Topalis D; Gillemot S; Snoeck R; Andrei G
    Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.
    Li X; Burton EM; Koganti S; Zhi J; Doyle F; Tenenbaum SA; Horn B; Bhaduri-McIntosh S
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio).
    Su M; Tang R; Wang H; Lu L
    Antiviral Res; 2021 Feb; 186():105000. PubMed ID: 33359191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.
    Liu X; Cohen JI
    Virology; 2015 May; 479-480():568-77. PubMed ID: 25798530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies for herpes viral infections (types 1 - 8).
    Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways.
    Šudomová M; Hassan STS
    Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33572685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of interferon and three antiviral agents on neurotropic and oncogenic herpesviruses.
    Daniel MD; Falk LA; King NW; Tamulevich R; Holland JS; Bekesi JG
    Antimicrob Agents Chemother; 1980 Oct; 18(4):622-8. PubMed ID: 6160810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive activities of natural products against herpesvirus infection.
    Son M; Lee M; Sung GH; Lee T; Shin YS; Cho H; Lieberman PM; Kang H
    J Microbiol; 2013 Oct; 51(5):545-51. PubMed ID: 24173639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy.
    Coen DM
    Antiviral Res; 1991 May; 15(4):287-300. PubMed ID: 1659311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.